SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Jay D. Horton(Center for Human Genetics), Michael S. Brown(Hospital of the University of Pennsylvania)
Cited by 3,979
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Molecular mediators of hepatic steatosis and liver injury
|Journal of Clinical Investigation|2004|1.8k
Receptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor System
|Annual Review of Cell Biology|1985|1.6k